GlassScriptPhysician profile
Naomi Collazo Gutierrez
NPI 1225427651
$6,053.56
in general payments reported to CMS, 2019-2025
15 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,199 · 2020: $588 · 2021: $689 · 2022: $895 · 2023: $1,815 · 2024: $358 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823 · Travel and Lodging: $785 · Education: $74.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.86 |
| Travel and Lodging | $784.57 |
| Education | $74.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,083.27 | 2019-2023 | Nim Vital, Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $978.40 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $887.04 | 2019-2025 | Farxiga, Lokelma |
| Eli Lilly Export S.A. Puerto Rico Branch | $629.89 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $440.65 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $410.07 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $315.62 | 2019-2023 | |
| Amgen INC. | $264.49 | 2019-2025 | Evenity, Repatha, Repatha |
| Dexcom, INC. | $264.28 | 2021-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $210.30 | 2019-2023 | Janumet, Steglatro, Segluromet |
| Abbott Laboratories | $170.59 | 2020-2023 | Freestyle Libre 3 |
| Ascensia Diabetes Care US INC. | $153.56 | 2023 | |
| Beta Bionics, INC. | $115.74 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Pfizer Pharmaceuticals LLC | $106.82 | 2019 | |
| Vifor Pharma, INC. | $22.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naomi Collazo Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.